incb047986
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2013 (NCT01929941)
Timeline
Indications
Mechanism of action
- Tyrosine-protein kinase JAK1INHIBITOR
JAK1 inhibitor
The compound is thought to be JAK1 selective but no selectivity data available.
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545225 ↗
Also known as
- incb047986
- incb-047986
- incb-47986
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02151474 | Phase 2 | May 1, 2014 | Incyte |
| NCT02093429 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2014 | Incyte |
| NCT01929941 | Phase 1 | Sep 1, 2013 | Incyte |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Incyte | For profit | 3 | 3 | 2 | 2013 |
1 organizations
Page 1 / 1